Recent Development News: Q4 – 2018

Arsanis and X4 Pharmaceuticals Agree to Merger

CAMBRIDGE, Mass. and WALTHAM, Mass. and VIENNA, Austria, Nov. 27, 2018 (GLOBE NEWSWIRE) — Arsanis, Inc. (Nasdaq: ASNS) and privately-held X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics designed to improve immune … Continue reading

Posted in Recent Development News: Q4 - 2018, Recent Developments | Comments Off